Skip to content
★ Sign in to follow
CE

Charlie e. Cheever III

CV Sciences, Inc.
Insider activity · 24 months10 buys0 salesCumulative net flow
Total declarations
10
Company
1
▲ Purchases (10 ops.)
€100k
▼ Sales (0 ops.)
—

Latest filing published 09 Sept 2026 for CV Sciences, Inc., €1,593.

Filing timeline

BuySale
Charlie e. Cheever III

Insider track record

Disclosed buys
10
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Charlie e. Cheever III: trading record in brief

Charlie e. Cheever III is a declared insider of CV Sciences, Inc., with filings sourced from SEC (Form 4). In total, 10 filings cover trades dated from 16 July 2026 to 7 August 2026.

On the market, this insider has only ever bought: 10 purchases, €100k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Half of the purchases are above €5,324 and half below. Scaled by market value, the purchases weigh a median 0.27% of market cap (sample: 10 purchases). The 10 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The record was last updated on 9 September 2026 with an open-market purchase (€1,593) in CV Sciences, Inc. Filings reach the SEC (Form 4) feed a median of 45 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Charlie e. Cheever III

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    1,828 USD0SEC
    91,387 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:0
    Canonical exit: 14 Oct 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    14,980 USD0SEC
    749,000 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:1
    Canonical exit: 15 Oct 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    6,700 USD0SEC
    335,000 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:2
    Canonical exit: 19 Oct 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    5,450 USD0SEC
    272,500 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:3
    Canonical exit: 20 Oct 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    9,402 USD0SEC
    470,075 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:4
    Canonical exit: 22 Oct 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    36,600 USD0SEC
    1,830,000 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:5
    Canonical exit: 26 Oct 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    1,200 USD0SEC
    60,000 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:6
    Canonical exit: 27 Oct 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    34,600 USD0SEC
    1,730,000 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:7
    Canonical exit: 29 Oct 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    2,160 USD0SEC
    108,000 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:8
    Canonical exit: 2 Nov 2026 (T+90)
  • ▲
    10% OwnerExecutivesCV Sciences, Inc.
    1,897 USD0SEC
    94,854 shares@ US$0.02Common Stock, $0.0001 par value per shareSEC:0001202557-26-000005:9
    Canonical exit: 5 Nov 2026 (T+90)

10 of 10 declarations